Previously, in a 6-OHDA-induced model of PD using selective Sigma1R ligands, we demonstrated the contribution of chaperone Sigma1R to the neuroprotective effect of a 14-day afobazole course started on the day of 6-OHDA lesion [22]. The gene discussed is SIGMAR1; the disease is Parkinson disease.